Purple Biotech Ltd. (NASDAQ/TASE: PPBT) presented preclinical data for its lead candidate IM1240 at the European Association for Cancer Research ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE